Y. Myoken et al., RELEASE OF FIBROBLAST GROWTH-FACTOR-I BY HUMAN SQUAMOUS-CELL CARCINOMA CORRELATES WITH AUTOCRINE CELL-GROWTH, In vitro cellular & developmental biology. Animal, 30A(11), 1994, pp. 790-795
A squamous cell carcinoma cell line Nakata proliferated in serum-free
culture and was not responsive to exogenous fibroblast growth factor-1
(FGF-1). Immunostaining revealed that Nakata cells expressed FGF-1 in
their cytoplasms and nuclei. Two molecular mass species of FGF-1 (16
and 18 kDa) were identified in cell extracts by Western blot. These ce
lls also expressed high-affinity FGF-1 binding sites (Kd = 360 pM, 28
000 sites/cell). The results of cross-linking with [I-125]FGF-1 demons
trated the presence of two bands with molecular masses of 160 and 140
kDa. The addition of FGF-1 specific antisense oligonucleotides at 25 m
u M to Nakata cells resulted in an 82% inhibition in cell growth and s
uppressed FGF-1 expression. This effect was dose-dependent and specifi
c, because sense oligonucleotides were ineffective in inhibiting cell
growth. In addition, Nakata cell growth was suppressed by an anti-FGF-
1 neutralizing antibody, which resulted in a 52% inhibition at 8 mu g/
ml. These results demonstrate that Nakata cells produce FGF-1, and ind
icate that this growth factor acts in an autocrine manner by interacti
ng with FGF-1 binding sites on Nakata cells.